Date:2020.06.22
National Healthcare Security Administration (NHSA) recently has issued a notice that, based on comprehensive consideration of COVID-19 prevention & control work need and the paying ability of local medical insurance fund, all regions in China should incorporate the nucleic acid testing (NAT) and related consumables into medical insurance in order, as well as determine payment conditions simultaneously.